Singota Solutions’ Featured in Online Exclusive: 3 Key Trends in the Industry

We are thrilled to announce that Singota Solutions (Bloomington, Indiana CDMO specializing in aseptic filling, drug development, formulation development, and supply chain management) is featured in Contract Pharma's latest Online Exclusive, "3 Key Trends," highlighting pivotal shifts in the pharmaceutical and biotech industry. This insightful article explores the emerging trends…

Understand Your Process: A Key To CMO Risk Mitigation

The global pharmaceutical industry outsourced an estimated $65 billion in drug manufacturing volume to contract manufacturing organizations (CMOs) in 2016, according to the research firm Mordor Intelligence. According to a December 2023 report, the sterile injectable drugs contract manufacturing outsourcing market is expected to exceed $24.2 billion in 2024. Pharmaceutical companies contract…

The Dating Game – Trust & Compatibility In Outsourcing Partnerships

When selecting a manufacturing outsourcing partner and outsourcing partnerships, it's essential to evaluate both trust and compatibility to navigate the complexities of the clinical trial pipeline effectively. Singota Solutions (Bloomington, Indiana CDMO) offers specialized aseptic manufacturing solutions (a small batch aseptic filler, aseptic filling, etc) that cater to early-phase clients.…

Systematic Approach To Early Phase Sterile Drug Product Technology Transfer

Initial scale-up of a sterile drug product manufacturing process (early phase) can present significant challenges and risks to new drug development timelines, budgets, product quality, and patient safety if not properly managed. At Singota Solutions (Bloomington, Indiana CDMO), our expertise in injectable formulation development, combined with our advanced aseptic manufacturing…

Creating A Streamlined Process For Establishing Mutual Confidentiality Disclosure Agreements With A CDMO

Navigating confidentiality disclosure agreements (CDAs) swiftly and effectively is essential for fostering trust and collaboration between clients and CDMOs in the pharmaceutical industry. With complexities such as disparities in templates and multi-party agreements, the process can be challenging. At Singota Solutions (Bloomington, Indiana CDMO), we leverage a combination of expertise…

New Technology Adoption In Aseptic Filling: Risk Aversion vs. Change Aversion

In the realm of pharmaceutical innovation, the pursuit of enhancement resonates profoundly. Singota Solutions (Bloomington, Indiana CDMO) leads the charge with its array of services spanning small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, GMP compliant warehouse facilities, and injectable formulation development. Delving into the dynamics of…

Microbiology Fulfills A Vital QC Role At A CDMO In Aseptic Filling And Sampling

In the dynamic landscape of pharmaceutical manufacturing, where precision and compliance are paramount, every step in the process plays a critical role in ensuring product efficacy and safety. From the meticulous development of injectable formulations to the stringent requirements of cold chain pharmaceutical storage, each phase demands meticulous attention to…

How Efficient Batch Records Serve Thorough Tech Transfer — Optimizing Aseptic Fill For Development Projects

As the pharmaceutical industry continues to advance, the need for efficient and effective technology transfer processes becomes increasingly crucial. From small batch aseptic filler, to cold chain pharmaceutical storage, companies are constantly seeking aseptic manufacturing solutions, preferably with GMP compliant warehouse facilities, to streamline injectable formulation development. However, the intricate…

Posts navigation